Resources from the same session
LBA1 - IL-10 expressing CD19 CAR-T cells induce complete remission and improve long-term protection in relapsed or refractory B-cell hematological malignancies
Presenter: Li Tang
Session: Proffered Paper session
Resources:
Abstract
1O - Exploration of Gut Microbiota Biomarkers in Treatment-Naïve Advanced NSCLC Patients Undergoing Chemo-Immunotherapy: Insights from the Phase III trial, JCOG2007 (NIPPON)
Presenter: Taiki Hakozaki
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session
Resources:
Webcast
2O - TILs and PD-L1 early dynamics in the randomized Neo-CheckRay phase II trial evaluating neo-adjuvant immuno-radiation and adenosine pathway blockade for early-stage, high risk ER+/HER2- breast cancer (BC)
Presenter: Alex De Caluwe
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
65O - CheckMate 73L: Phase 3 study comparing nivolumab (N) + concurrent chemoradiotherapy (CCRT) followed by N _ ipilimumab (I) v CCRT followed by durvalumab (D) for previously untreated, locally advanced stage (stg) III NSCLC
Presenter: Solange Peters
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
117O - Stereotactic Body Radiotherapy (SBRT) With Pembrolizumab (pembro) for Unresected Stage I/II Non-Small-Cell Lung Cancer (NSCLC): The Randomized, Double-Blind, Phase 3 KEYNOTE-867 Study
Presenter: Andreas Pircher
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
Invited Discussant 2O, 65O and 117O
Presenter: Kevin Harrington
Session: Proffered Paper session
Resources:
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session
Resources:
Webcast